The liquid biopsy of plasma samples showed higher specificity for the detection of EGFR mutations in patients with NSCLC, whereas tissue biopsy was still required for the evaluation of patients with negative liquid biopsy due to its lower sensitivity [23]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.